HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Young Joo Jeon Selected Research

Primary Ovarian Insufficiency

2/2015Association study of five functional polymorphisms in matrix metalloproteinase-2, -3, and -9 genes with risk of primary ovarian insufficiency in Korean women.
3/2014Association of five common polymorphisms in the plasminogen activator inhibitor-1 gene with primary ovarian insufficiency.
2/2014Association of inhibin α gene promoter polymorphisms with risk of idiopathic primary ovarian insufficiency in Korean women.
10/2013Association of polymorphisms in microRNA machinery genes (DROSHA, DICER1, RAN, and XPO5) with risk of idiopathic primary ovarian insufficiency in Korean women.
5/2013Association between polymorphisms in renin-angiotensin system genes and primary ovarian insufficiency in Korean women.
2/2013Association of nitric oxide synthase gene polymorphisms (-786T>C, 4a4b, 894G>T) with primary ovarian insufficiency in Korean women.
1/2013Association of miR-146aC>G, miR-196a2T>C, and miR-499A>G polymorphisms with risk of premature ovarian failure in Korean women.
11/2012Association of methylenetetrahydrofolate reductase (MTHFR 677C>T) and thymidylate synthase (TSER and TS 1494del6) polymorphisms with premature ovarian failure in Korean women.
11/2012Tumor necrosis factor-alpha promoter polymorphisms are associated with idiopathic primary ovarian insufficiency in Korean women.
9/2012Association between kinase insert domain-containing receptor polymorphisms (-604T>C, 1192G>A, 1719A>T) and premature ovarian failure in Korean women.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Young Joo Jeon Research Topics

Disease

15Neoplasms (Cancer)
12/2018 - 07/2012
11Primary Ovarian Insufficiency
02/2015 - 11/2011
9Colorectal Neoplasms (Colorectal Cancer)
06/2015 - 11/2011
6Spontaneous Abortion (Miscarriage)
09/2014 - 12/2011
4Metabolic Syndrome (Dysmetabolic Syndrome X)
05/2015 - 01/2013
4Ischemic Stroke
01/2015 - 01/2013
4Moyamoya Disease (Moya-Moya Disease)
10/2014 - 01/2012
3Inflammation (Inflammations)
10/2018 - 11/2012
3Carcinogenesis
02/2017 - 07/2012
3Breast Neoplasms (Breast Cancer)
03/2015 - 10/2014
2Hypertension (High Blood Pressure)
05/2015 - 06/2014
2Stroke (Strokes)
01/2015 - 02/2013
2Rectal Neoplasms (Rectal Cancer)
11/2014 - 12/2013
2Thrombosis (Thrombus)
10/2014 - 10/2013
2Venous Thromboembolism
06/2013 - 07/2012
1Female Infertility
02/2018
1Neoplasm Metastasis (Metastasis)
06/2015
1Brain Infarction
01/2015
1Vascular Diseases (Vascular Disease)
01/2015
1Colonic Neoplasms (Colon Cancer)
11/2014
1Hyperhomocysteinemia
10/2014
1Brain Ischemia (Cerebral Ischemia)
10/2014
1Trisomy 18 Syndrome
01/2014
1Stomach Neoplasms (Stomach Cancer)
11/2013
1Atherosclerosis
02/2013
1Cardiovascular Diseases (Cardiovascular Disease)
02/2013
1Hepatocellular Carcinoma (Hepatoma)
08/2012
1Ischemia
07/2012
1Reperfusion Injury
07/2012
1Hypoxia (Hypoxemia)
11/2011
1Immune System Diseases (Immune Disorders)
05/2010
1Melanoma (Melanoma, Malignant)
12/2008

Drug/Important Bio-Agent (IBA)

11MicroRNAs (MicroRNA)IBA
06/2015 - 11/2011
7Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2018 - 11/2011
6Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA
06/2015 - 11/2012
5Folic Acid (Vitamin M)FDA LinkGeneric
05/2015 - 02/2013
4Proteins (Proteins, Gene)FDA Link
10/2018 - 05/2010
4HomocysteineIBA
01/2015 - 02/2013
4Phosphotransferases (Kinase)IBA
11/2013 - 01/2012
3Nitric Oxide (Nitrogen Monoxide)FDA Link
10/2014 - 01/2013
2Glutamine (L-Glutamine)FDA Link
03/2015 - 01/2015
2Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA
09/2014 - 02/2013
2Thymidylate SynthaseIBA
01/2014 - 11/2012
2Reduced Folate Carrier ProteinIBA
01/2014 - 05/2012
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
04/2013 - 11/2012
2Annexin A1IBA
11/2012 - 07/2012
1UbiquitinsIBA
12/2018
1Proliferating Cell Nuclear Antigen (PCNA)IBA
02/2017
1VitaminsIBA
05/2015
1Paclitaxel (Taxol)FDA LinkGeneric
03/2015
1Carrier Proteins (Binding Protein)IBA
03/2015
1Follicle Stimulating Hormone (Follitropin)FDA Link
02/2015
1Matrix Metalloproteinase 2 (Gelatinase A)IBA
02/2015
1Estradiol (Delestrogen)FDA LinkGeneric
02/2015
1Estrogen ReceptorsIBA
01/2015
1UbiquitinIBA
01/2015
1Hormones (Hormone)IBA
01/2015
1SteroidsIBA
01/2015
1Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
01/2015
1Transcription Factors (Transcription Factor)IBA
01/2015
1Pharmaceutical PreparationsIBA
10/2014
1TamoxifenFDA LinkGeneric
10/2014
1EnzymesIBA
10/2014
1Tissue Inhibitor of Metalloproteinase-2IBA
10/2014
1Matrix Metalloproteinases (MMPs)IBA
10/2014
1Tissue Inhibitor of MetalloproteinasesIBA
10/2014
1Transcobalamins (Transcobalamin II)IBA
09/2014
1Plasminogen Activators (Plasminogen Activator)IBA
03/2014
1Inhibins (Inhibin)IBA
02/2014
1Fluorouracil (Carac)FDA LinkGeneric
01/2014
1Protons (Proton)IBA
01/2014
1Genetic Markers (Genetic Marker)IBA
12/2013
1Plasminogen Activator Inhibitor 1IBA
10/2013
1Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
05/2013
1AngiotensinogenIBA
05/2013
1Type 1 Angiotensin ReceptorIBA
05/2013
1DNA (Deoxyribonucleic Acid)IBA
02/2013
1Nitric Oxide Synthase (NO Synthase)IBA
02/2013
1Therapeutic UsesIBA
07/2012
1Purinergic P2 Receptors (ADP Receptor)IBA
07/2012
1Doxorubicin (Adriamycin)FDA LinkGeneric
07/2012
1Hypoxia-Inducible Factor 1IBA
11/2011
1Biological ProductsIBA
05/2010
1FilaminsIBA
12/2008

Therapy/Procedure

2Therapeutics
10/2018 - 01/2015
2Drug Therapy (Chemotherapy)
03/2015 - 01/2014
1Semiconductors
01/2014